SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Lone Star Bio
Making Exercise Fun For Wheelchair Users, University of Texas
September 11, 2008
 · 
1 min read
Lone Star Bio
University of North Texas to Launch $25 Million Research Effort
September 10, 2008
 · 
1 min read
Lone Star Bio
Protein ‘Switch’ Suppresses Skin Cancer Development, University of Texas MD Anderson Cancer Center Study
September 10, 2008
 · 
1 min read
Lone Star Bio
Blood Pressure Treatment Can Be Used Against Stroke; University of Texas Medical School Study Finds The Therapy Can Be Given In Tandem With Clot-Dissolving Drug
September 10, 2008
 · 
1 min read
Drug Development
Change In HER2 Status Found After Treating Breast Cancer Patients With Herceptin, University of Texas MD Anderson Cancer Center Study
September 8, 2008
 · 
1 min read
Lone Star Bio
Infectious, Test Tube-Produced Prions Can Jump The ‘Species Barrier’ -- University of Texas Study
September 5, 2008
 · 
1 min read
Drug Development
Antidepressants Need New Nerve Cells To Be Effective, University of Texas Southwestern Medical Center Researchers Find
August 29, 2008
 · 
1 min read
Lone Star Bio
Laser Microscalpel to Target Cancers Individually, University of Texas Study
August 29, 2008
 · 
1 min read
Lone Star Bio
Gout Drug Cuts Teen High Blood Pressure; Allopurinol Lowers Teen Blood Pressure but Isn’t the Ultimate Answer, Baylor College of Medicine Researcher Says
August 27, 2008
 · 
1 min read
Lone Star Bio
Rutgers University and University of Texas Researchers Determine 3-D Structure Of A Key Site On A Flu Protein That Suppresses Human Defenses To Infection
August 26, 2008
 · 
1 min read
Load More
PRESS RELEASES
Press Releases
Medicenna Therapeutics Announces Key Program Updates and 2026 Outlook
January 16, 2026
 · 
11 min read
Press Releases
Gradalis’ Vigil® Demonstrates Significant Survival Benefit in cTMB-H / HRP Ovarian Cancer Patients; Phase 2b VITAL Trial Analysis Published in JCO – Precision Oncology
January 15, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Announces Pricing of Upsized $15 Million Public Offering
January 15, 2026
 · 
5 min read
Press Releases
Moleculin Reports Independent Assessment Confirms No Cardiotoxicity of Annamycin in 90 Subjects
January 14, 2026
 · 
6 min read
Press Releases
Omnicell to Release Fourth Quarter and Full Year 2025 Financial Results on February 5, 2026
January 13, 2026
 · 
1 min read
Press Releases
Decoy Therapeutics Reaches Global Access Commitment Agreement to Focus on Development of a Globally Accessible, Scalable Peptide-Conjugate Manufacturing Platform
January 13, 2026
 · 
7 min read
Press Releases
Cassava Announces Publication of Peer-Reviewed Phase 3 Results for Simufilam in Alzheimer’s Disease in the Journal of Prevention of Alzheimer’s Disease
January 13, 2026
 · 
9 min read
Press Releases
TYBR Health Appoints Jeff Tyber to Board of Directors
January 13, 2026
 · 
2 min read
Press Releases
Tivic Delivers 200x Scale-up in Manufacturing for Lead Drug Candidate Entolimod(TM) And Achieves Reproducible Yields, Potency and Purity
January 13, 2026
 · 
6 min read
Press Releases
Caris Life Sciences Announces Preliminary Fourth Quarter and Full Year 2025 Results
January 13, 2026
 · 
7 min read
Load More